SCHEMBL31701702

CC(=O)N[C@H]1[C@H](OC[C@H]2O[C@@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)O[C@@H]3CO)[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O[C@H]5O[C@H](CO)[C@H](O)[C@H](O)[C@H]5NC(C)=O)[C@H]4NC(C)=O)[C@H]3O)[C@H]2O)O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@@H]1O

nearest known ligand 0.60

Predicted protein targets (top 14)

	gene	UniProt	supporting neighbours	confidence
▸	LGALS3	P17931	5/20	0.60

▸	LGALS8	O00214	1/20	0.60

▸	LGALS4	P56470	1/20	0.60

▸	AMY2A	P04746	3/20	0.49

▸	CD209	Q9NNX6	2/20	0.49

▸	CD69	Q07108	1/20	0.48

▸	MAPK1	P28482	1/20	0.48

▸	CHIA	Q9BZP6	1/20	0.48

▸	ENGASE	Q8NFI3	1/20	0.48

▸	HPSE	Q9Y251	2/20	0.47

▸	LGALS1	P09382	1/20	0.45

▸	LGALS7; LGALS7B	P47929	1/20	0.45

▸	ALDH1A1	P00352	1/20	0.45

▸	THRB	P10828	1/20	0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL31700839	0.99	LGALS3 (0.61)	LGALS3LGALS8LGALS4AMY2ACD209
SCHEMBL31700920	0.99	LGALS3 (0.61)	LGALS3LGALS8LGALS4AMY2ACD209
SCHEMBL31700328	0.99	LGALS3 (0.61)	LGALS3LGALS8LGALS4AMY2ACD209
SCHEMBL31701594	0.99	LGALS3 (0.59)	LGALS3LGALS8LGALS4AMY2ACD209
SCHEMBL31700437	0.99	LGALS3 (0.61)	LGALS3LGALS8LGALS4AMY2ACD209
SCHEMBL31701587	0.99	LGALS3 (0.59)	LGALS3LGALS8LGALS4AMY2ACD209
SCHEMBL31701084	0.99	LGALS3 (0.61)	LGALS3LGALS8LGALS4AMY2ACD209
SCHEMBL31694314	0.99	LGALS3 (0.61)	LGALS3LGALS8LGALS4AMY2ACD209
SCHEMBL31700161	0.99	LGALS3 (0.61)	LGALS3LGALS8LGALS4AMY2ACD209
SCHEMBL31700351	0.99	LGALS3 (0.61)	LGALS3LGALS8LGALS4AMY2ACD209

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20250319190-A1	APOE LIPOPROTEIN SYSTEMS	KISBEE THERAPEUTICS INC (US)	2025-10-16	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20250319190-A1	APOE LIPOPROTEIN SYSTEMS	APOB, APOL1, LDLR	LGALS3 236/4885LGALS8 242/4885LGALS4 287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.